Lumexa rises after Truist initiates with Buy
LMRI•Lumexa Imaging shares rose 2% premarket after Truist Securities initiated coverage with a Buy rating and an $18 price target, implying about 74% upside to the last close.
1. Truist starts coverage
Truist Securities initiated coverage of Lumexa Imaging with a Buy rating and an $18 price target. All five brokerages covering the stock have a Buy or higher rating, with a median price target of $17.50; Lumexa shares were down 44.22% year to date as of the last close.
